Elevated blood GFAP and NfL levels can be observed in other neurodegenerative diseases (e.g., Parkinson’s disease, amyotrophic lateral sclerosis), stroke, or traumatic brain injury [56,57]. This evidence concerns the gene GFAP and neurodegenerative disease.